Published Oct 20, 2026, 8:50 AM ET · Updated 24 days ago · 2 sources
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
CNBC Markets
·
Original Report
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.